Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | CZARNECKI Ryszard ( ECR) | ZDECHOVSKÝ Tomáš ( EPP), RÓNAI Sándor ( S&D), STRUGARIU Ramona ( Renew), EICKHOUT Bas ( Verts/ALE), OMARJEE Younous ( GUE/NGL) |
Committee Opinion | ENVI | ||
Committee Opinion | LIBE | CHINNICI Caterina ( S&D) | Clare DALY ( GUE/NGL), Peter KOFOD ( ID) |
Lead committee dossier:
Subjects
Events
The European Parliament decided by 636 votes to 53, with 9 abstentions, to give discharge to the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the financial year 2019 and to approve the closure of the accounts for that year.
Noting that the Court of Auditors stated that it had obtained reasonable assurance that the Centre's annual accounts for the financial year 2019 were reliable and that the underlying transactions were legal and regular, Parliament adopted, by 628 votes to 58 with 5 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
Centre’s financial statements
The EMCDDA's final budget for the financial year 2019 was EUR 18 178 352.57, which is an increase of 12.39% compared to 2018. The increase in the budget is mainly due to the launch of the new Instrument for Pre-Accession Assistance 7 (IPA 7).
Budgetary and financial management
Parliament welcomed the budget monitoring efforts made during the 2019 financial year, which resulted in a budget implementation rate of 100%, identical to that recorded in 2018. The implementation rate of payment appropriations was 98.29%, an increase of 0.28% compared to the previous year.
Other observations
Members also made a series of observations concerning performance, staff, procurement, conflict of interest management and internal controls.
In particular, they noted that:
- the 2019 work programme is largely implemented and the Centre has introduced a new performance measurement model in 2019;
- the Centre plays an important role in providing policy makers and practitioners with a range of analysis and information on drugs and drug addiction and trends, with a view to effectively combating drug abuse and trafficking;
- the Centre partially met its objective in terms of training days per staff member, in terms of public service costs and in terms of its contribution to 14 major scientific and practice drug events;
- on 31 December 2019, 94.74% of the establishment plan was executed with 9 officials and 63 temporary agents appointed out of the 10 officials and 66 temporary agents authorised under the Union's budget;
- the Centre recorded a close gender balance within the Management Board in 2019 (16 men and 14 women) but the geographical balance of staff needs to be improved;
- the issue of dependence on external recruitment needs to be addressed and applicable labour law respected;
- in 85 out of 92 procedures, representing 60% of the total value of the contracts, the Centre attributed direct contracts in procedures with single tenders. Members recommended the use of procedures involving multi candidates, even for low-value contracts;
- the Centre has taken steps to ensure transparency, prevent and manage conflicts of interest and protect whistleblowers; Members called for the creation of a common ethical framework for all EU institutions and agencies;
- the final version of the repository for the new internal control framework was approved by the Centre’s Director in March 2019 but the anti-fraud strategy should be updated.
Documents
- Decision by Parliament: T9-0177/2021
- Debate in Parliament: Debate in Parliament
- Committee report tabled for plenary, single reading: A9-0087/2021
- Committee report tabled for plenary: A9-0087/2021
- Amendments tabled in committee: PE680.788
- Committee opinion: PE661.917
- Supplementary non-legislative basic document: 05793/2021
- Committee draft report: PE657.224
- Non-legislative basic document: COM(2020)0288
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2020)0288
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2020)0288 EUR-Lex
- Committee draft report: PE657.224
- Supplementary non-legislative basic document: 05793/2021
- Committee opinion: PE661.917
- Amendments tabled in committee: PE680.788
- Committee report tabled for plenary, single reading: A9-0087/2021
Votes
Décharge 2019 : Observatoire européen des drogues et des toxicomanies - 2019 discharge: European Monitoring Centre for Drugs and Drug Addiction - Entlastung 2019: Europäische Beobachtungsstelle für Drogen und Drogensucht - A9-0087/2021 - Ryszard Czarnecki - Propositions de décision #
Décharge 2019 : Observatoire européen des drogues et des toxicomanies - 2019 discharge: European Monitoring Centre for Drugs and Drug Addiction - Entlastung 2019: Europäische Beobachtungsstelle für Drogen und Drogensucht - A9-0087/2021 - Ryszard Czarnecki - Am 1/1 #
A9-0087/2021 - Ryszard Czarnecki - Am 1/2 #
Décharge 2019 : Observatoire européen des drogues et des toxicomanies - 2019 discharge: European Monitoring Centre for Drugs and Drug Addiction - Entlastung 2019: Europäische Beobachtungsstelle für Drogen und Drogensucht - A9-0087/2021 - Ryszard Czarneck - Proposition de résolution #
Amendments | Dossier |
11 |
2020/2153(DEC)
2021/01/19
LIBE
11 amendments...
Amendment 1 #
Draft opinion Paragraph 1 1. Highlights the important role of the European Monitoring Centre for Drugs and Drug Addiction (the 'Centre’) in providing policy-makers and practitioners with analyses and information concerning drugs and drug addiction as well as emerging trends with a view to effectively countering illicit drug use and trafficking and in contributing to a healthier Europe by addressing important drug-related public health concerns; recalls that drug trafficking has been identified as a main source of profit and a channel of recruitment for organised crime and terrorism, and therefore highlights the contribution of the Centre also to a more secure Europe;
Amendment 10 #
Draft opinion Paragraph 3 b (new) 3 b. Highlights the contribution of the Centre, by means of its annual reports, to the development of the EU Agenda and Action Plan on Drugs 2021-20251a, and the role the Centre is going to play in its implementation; _________________ 1a COM(2020) 606 final.
Amendment 11 #
Draft opinion Paragraph 3 b (new) 3 b. Underlines the important effect of turnover within the staff of the Union agencies; calls for the implementation of human and social policies to remedy it.
Amendment 2 #
Draft opinion Paragraph 2 a (new) 2 a. Calls on the agency to continue to develop its synergies, increase cooperation and exchange of good practices with other European agencies with a view to improve efficiency (human resources, building management, IT services and security);
Amendment 3 #
Draft opinion Paragraph 2 b (new) 2 b. Welcomes the cooperation between the Centre and EUROPOL; acknowledges the publication of their third joint report on EU Drug Markets and its supporting digital information package; notes the two new cooperations at institutional level with the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA), in order to implement the New Psychoactive Substances legislation;
Amendment 4 #
Draft opinion Paragraph 3 3. Reiterates its concern that the Court has identified a
Amendment 5 #
Draft opinion Paragraph 3 3. Reiterates its concern that the Court has identified a horizontal trend across agencies in the use of external staff hired in IT consultancy roles; calls for the dependency on external recruitment in this important area to be addressed; notes the pending case before the CJEU as regards the use of interim workers by EMCDDA, addressing several questions concerning the application of Directive 2008/104/EC of the European Parliament and of the Council of 19 November 2008 on temporary agency workers to EU agencies
Amendment 6 #
Draft opinion Paragraph 3 3. Reiterates its concern that the Court has identified a horizontal trend across agencies in the use of external staff hired in IT consultancy roles; calls for the dependency on external recruitment in this important area to be addressed; notes the pending case before the CJEU as regards the use of interim workers by EMCDDA, addressing several questions concerning the application of Directive 2008/104/EC of the European Parliament and of the Council of 19 November 2008 on temporary agency workers to EU agencies
Amendment 7 #
Draft opinion Paragraph 3 a (new) 3 a. Stresses the importance to increase the digitalisation of the agency in terms of internal operation and management but also in order to speed up the digitalisation of procedures; stresses the need for the agency to continue to be proactive in this regard in order to avoid a digital gap between the agencies at all costs; draws attention, however, to the need to take all the necessary security measures to avoid any risk to the online security of the information processed;
Amendment 8 #
Draft opinion Paragraph 3 a (new) 3 a. Welcomes the fact that the observation of the Court regarding the financial contribution from Norway to the Centre, which was not in line with the envisaged contribution mechanism, has been acted upon and completed;
Amendment 9 #
Draft opinion Paragraph 3 a (new) 3 a. EU institutions must rigorously comply with financial regulation and high management standards;
source: 663.238
|
History
(these mark the time of scraping, not the official date of the change)
events/0/date |
Old
2020-06-29T00:00:00New
2020-06-28T00:00:00 |
events/6 |
|
procedure/final |
|
procedure/stage_reached |
Old
Procedure completed, awaiting publication in Official JournalNew
Procedure completed |
events/4/docs |
|
docs/6 |
|
events/5/summary |
|
docs/6 |
|
events/5 |
|
procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed, awaiting publication in Official Journal |
events/1/body |
EP
|
events/2/body |
EP
|
events/3/body |
EP
|
events/4 |
|
forecasts |
|
docs/1/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE657.224New
https://www.europarl.europa.eu/doceo/document/CONT-PR-657224_EN.html |
docs/3/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE661.917&secondRef=02New
https://www.europarl.europa.eu/doceo/document/LIBE-AD-661917_EN.html |
docs/4/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE680.788New
https://www.europarl.europa.eu/doceo/document/CONT-AM-680788_EN.html |
docs/5 |
|
events/1 |
|
events/1 |
|
events/2 |
|
events/2 |
|
events/3/docs |
|
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
committees/0 |
|
committees/0 |
|
events/2 |
|
forecasts |
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
docs/4/docs/0/url |
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE680.788
|
docs/4/date |
Old
2021-03-03T00:00:00New
2021-03-04T00:00:00 |
docs/4/date |
Old
2021-03-01T00:00:00New
2021-03-03T00:00:00 |
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
docs/4 |
|
commission |
|
docs/3 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
docs/2 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
committees/0 |
|
committees/0 |
|
committees/2 |
|
committees/2 |
|
docs/1 |
|
committees/0 |
|
committees/0 |
|
committees/2/rapporteur/0/mepref |
124861
|
committees/0 |
|
committees/0 |
|
committees/2/rapporteur |
|
committees/1/opinion |
False
|
events/1 |
|
procedure/dossier_of_the_committee |
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
committees/0/rapporteur |
|
committees/0 |
|
committees/0 |
|
committees/0/shadows |
|